Afferent Pathway-Mediated Effect of α1 Adrenergic Antagonist, Tamsulosin, on the Neurogenic Bladder After Spianl Cord Injury
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Purpose: The functions of the lower urinary tract (LUT), such as voiding and storing urine, are dependent on complex central neural networks located in the brain, spinal cord, and peripheral ganglia. Thus, the functions of the LUT are susceptible to various neurologic disorders including spinal cord injury (SCI). SCI at the cervical or thoracic levels disrupts voluntary control of voiding and the normal reflex pathways coordinating bladder and sphincter functions. In this context, it is noteworthy that α1-adrenoceptor blockers have been reported to relieve voiding symptoms and storage symptoms in elderly men with benign prostatic hyperplasia (BPH). Tamsulosin, an α1-adrenoceptor blocker, is also considered the most effective regimen for patients with LUT symptoms such as BPH and overactive bladder (OAB). Methods: In the present study, the effects of tamsulosin on the expression of c-Fos, nerve growth factor (NGF), and nicotinamide adenine dinucleotide phosphate-diaphorase (NADPH-d) in the afferent micturition areas, including the pontine micturition center (PMC), the ventrolateral periaqueductal gray matter (vlPAG), and the spinal cord (L5), of rats with an SCI were investigated. Results: SCI was found to remarkably upregulate the expression of c-Fos, NGF, and NADPH-d in the afferent pathway of micturition, the dorsal horn of L5, the vlPAG, and the PMC, resulting in the symptoms of OAB. In contrast, tamsulosin treatment significantly suppressed these neural activities and the production of nitric oxide in the afferent pathways of micturition, and consequently, attenuated the symptoms of OAB. Conclusions: Based on these results, tamsulosin, an α1-adrenoceptor antagonist, could be used to attenuate bladder dysfunction following SCI. However, further studies are needed to elucidate the exact mechanism and effects of tamsulosin on the afferent pathways of micturition.
Abstract
Purpose: The functions of the lower urinary tract (LUT), such as voiding and storing urine, are dependent on complex central neural networks located in the brain, spinal cord, and peripheral ganglia. Thus, the functions of the LUT are susceptible to various neurologic disorders including spinal cord injury (SCI). SCI at the cervical or thoracic levels disrupts voluntary control of voiding and the normal reflex pathways coordinating bladder and sphincter functions. In this context, it is noteworthy that α1-adrenoceptor blockers have been reported to relieve voiding symptoms and storage symptoms in elderly men with benign prostatic hyperplasia (BPH). Tamsulosin, an α1-adrenoceptor blocker, is also considered the most effective regimen for patients with LUT symptoms such as BPH and overactive bladder (OAB). Methods: In the present study, the effects of tamsulosin on the expression of c-Fos, nerve growth factor (NGF), and nicotinamide adenine dinucleotide phosphate-diaphorase (NADPH-d) in the afferent micturition areas, including the pontine micturition center (PMC), the ventrolateral periaqueductal gray matter (vlPAG), and the spinal cord (L5), of rats with an SCI were investigated. Results: SCI was found to remarkably upregulate the expression of c-Fos, NGF, and NADPH-d in the afferent pathway of micturition, the dorsal horn of L5, the vlPAG, and the PMC, resulting in the symptoms of OAB. In contrast, tamsulosin treatment significantly suppressed these neural activities and the production of nitric oxide in the afferent pathways of micturition, and consequently, attenuated the symptoms of OAB. Conclusions: Based on these results, tamsulosin, an α1-adrenoceptor antagonist, could be used to attenuate bladder dysfunction following SCI. However, further studies are needed to elucidate the exact mechanism and effects of tamsulosin on the afferent pathways of micturition.
참고문헌 (35)
- Rickey LM, "Estrogen-sensitive projections from the medial preoptic area to the dorsal pontine tegmentum, including Barrington’s nucleus, in the rat", Neurourol Urodyn, 27, pp.440~445 (2008)
- Marson L., "Identification of central nervous system neurons that innervate the bladder body, bladder base, or external urethral sphincter of female rats: a transneuronal tracing study using pseudorabies virus", J Comp Neurol, 389, pp.584~602 (1997)
- Kavia RB, "Functional imaging and the central control of the bladder", J Comp Neurol, 493, pp.27~32 (2005)
- Blok BF, "Brain control of the lower urinary tract", Scand J Urol Nephrol, (210), pp.11~15 (2002)
- Saban MR, "Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation", Am J Pathol, 160, pp.2095~2110 (2002)
- Hiroi N, "FosB mutant mice : loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine’s psychomotor and rewarding effects", Proc Natl Acad Sci USA, 94, pp.10397~10402 (1997)
- Steers WD, "Mechanisms of disease : the role of nerve growth factor in the pathophysiology of bladder disorders", Nat Clin Pract Urol, 3, pp.101~110 (2006)
- Ho MH, "Physiologic role of nitric oxide and nitric oxide synthase in female lower urinary tract", Curr Opin Obstet Gynecol, 16, pp.423~429 (2004)
- Zhang F, "Neurochemical plasticity of nitric oxide synthase isoforms in neurogenic detrusor overactivity after spinal cord injury", Neurochem Res, 36, pp.1903~1909 (2011)
- de Groat WC, "Changes in afferent activity after spinal cord injury", Neurourol Urodyn, 29, pp.63~76 (2010)
- de Groat WC, "Afferent nerve regulation of bladder function in health and disease", Handb Exp Pharmacol, (194), pp.91~138 (2009)
- Cruz CD, "Spinal cord injury and bladder dysfunction : new ideas about an old problem", Scientific World Journal, 11, pp.214~234 (2011)
- de Groat WC, "Mechanisms underlying the recovery of lower urinary tract function following spinal cord injury", Prog Brain Res, 152, pp.59~84 (2006)
- Miyazato M, "An alpha1-adrenoceptor blocker terazosin improves urine storage function in the spinal cord in spinal cord injured rats", Life Sci, 92, pp.125~130 (2013)
- Yazaki J, "Alpha1-adrenoceptor antagonists improve bladder storage function through reduction of afferent activity in rats with bladder outlet obstruction", Neurourol Urodyn, 30, pp.461~467 (2011)
- Roehrborn CG, "The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study", J Urol, 179, pp.616~621 (2008)
- Yokoyama O, "Improvement in bladder storage function by tamsulosin depends on suppression of C-fiber urethral afferent activity in rats", J Urol, 177, pp.771~775 (2007)
- Abrams P, "Tamsulosin: efficacy and safety in patients with neurogenic lower urinary tract dysfunction due to suprasacral spinal cord injury", J Urol, 170(4 Pt 1), pp.1242~1251 (2003)
- Cho YS, "Oral mucosa stem cells alleviates spinal cord injury-induced neurogenic bladder symptoms in rats", J Biomed Sci, 21, pp.43~ (2014)
- 김성은, "Effects of Tamsulosin on Urinary Bladder Function and Neuronal Activity in the Voiding Centers of Rats with Cyclophosphamide-induced Overactive Bladder", International Neurourology Journal, 16(1), pp.13~22 (2012), 대한배뇨장애요실금학회
- Yezierski RP, "Spinal cord injury pain : spinal and supraspinal mechanisms", J Rehabil Res Dev, 46, pp.95~107 (2009)
- Kim SE, "An animal study to compare the degree of the suppressive effects on the afferent pathways of micturition between tamsulosin and sildenafil", J Biomed Sci, 20, pp.81~ (2013)
- Fowler CJ, "A decade of functional brain imaging applied to bladder control", Neurourol Urodyn, 29, pp.49~55 (2010)
- Qiao LY, "Spinal cord injury-induced expression of TrkA, TrkB, phosphorylated CREB, and c-Jun in rat lumbosacral dorsal root ganglia", J Comp Neurol, 482, pp.142~154 (2005)
- Ochodnický P, "Nerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic target", Neurourol Urodyn, 30, pp.1227~1241 (2011)
- Yoshimura N, "Bladder overactivity and hyperexcitability of bladder afferent neurons after intrathecal delivery of nerve growth factor in rats", J Neurosci, 26, pp.10847~10855 (2006)
- Vizzard MA, "Neurochemical plasticity and the role of neurotrophic factors in bladder reflex pathways after spinal cord injury", Prog Brain Res, 152, pp.97~115 (2006)
- Sugaya K, "Central nervous control of micturition and urine storage", J Smooth Muscle Res, 41, pp.117~132 (2005)
- Kakizaki H, "Role of spinal nitric oxide in the facilitation of the micturition reflex by bladder irritation", J Urol, 155, pp.355~360 (1996)
- Lagos P, "Role of spinal nitric oxide synthase-dependent processes in the initiation of the micturition hyperreflexia associated with cyclophosphamide-induced cystitis", Neuroscience, 125, pp.663~670 (2004)
- Vincent SR, "Histochemical mapping of nitric oxide synthase in the rat brain", Neuroscience, 46, pp.755~784 (1992)
- Andersson KE, "Overactive bladder-pharmacological aspects", Scand J Urol Nephrol, (210), pp.72~81 (2002)
- Avelino A, "Vanilloid receptor 1 expression in the rat urinary tract", Neuroscience, 109, pp.787~798 (2002)
- Seki S, "Suppression of detrusor-sphincter dyssynergia by immunoneutralization of nerve growth factor in lumbosacral spinal cord in spinal cord injured rats", J Urol, 171, pp.478~482 (2004)
- Callsen-Cencic P, "Increased spinal expression of c-Fos following stimulation of the lower urinary tract in chronic spinal cord-injured rats", Histochem Cell Biol, 112, pp.63~72 (1999)